Actionable news
All posts from Actionable news
Actionable news in AGIO: Agios Pharmaceuticals, Inc.,

Perilous Reversal Watch: Agios Pharmaceuticals (AGIO)

Trade-Ideas LLC identified Agios Pharmaceuticals ( AGIO) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Agios Pharmaceuticals as such a stock due to the following factors:

  • AGIO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $25.6 million.
  • AGIO has traded 153,572 shares today.
  • AGIO is down 3.4% today.
  • AGIO was up 9.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in AGIO with the Ticky from Trade-Ideas. See the FREE profile for AGIO NOW at Trade-Ideas More details on AGIO: Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders in the United States. Currently there are 2 analysts that rate Agios Pharmaceuticals a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for Agios Pharmaceuticals has been 707,100 shares per day over the past 30 days. Agios has a market cap of $1.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.94 and a...